The product portfolio of Zhejiang Tianyuan Bio- Pharmaceutical Co., Ltd consists of viral vaccines against Influenza (inactivated, split), Haemorrhagic Fever with Renal Syndrome (HFRS) and Japanese Encephalitis Virus (JEV).

Since 2006 the clean room facility in the existing production building was extended and 3 dedicated workshops for the production of bacterial vaccines against Meningococcal/ Typhoid, Diphtheria/Pertussis and Tetanus were set-up.

With a fast growing market, newly completed production, quality control and R&D facilities, and several other new vaccines in the pipeline, Tianyuan expects to see a steady business growth in the next years.